Please use this identifier to cite or link to this item:
|Title:||TRIPS—Fifteen Years and After|
|Abstract:||The TRIPS agreement has not been able to deliver the benefits promised to developing countries, which now need to plan ways to ensure that strict IP regimes do not become a tool for pharma companies in developed countries to milk the poor in the developing world.|
|Appears in Collections:||SR Vol.48(09) [September 2011]|
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.